Advertisement

Topics

Long- vs. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

19:00 EST 30 Nov 2016 | NEJM

Long-term DAPT raised bleeding risk without lowering risk for adverse cardiovascular outcomes, regardless of diabetes status.

Original Article: Long- vs. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

NEXT ARTICLE

More From BioPortfolio on "Long- vs. Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation"

Quick Search
Advertisement